Randomized Clinical Trial of Labetalol Versus Hydralazine for Severe Hypertension in Obstetric Patients.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02050529|
Recruitment Status : Unknown
Verified January 2014 by Saima Aziz Siddiqui, Dow University of Health Sciences.
Recruitment status was: Recruiting
First Posted : January 30, 2014
Last Update Posted : January 30, 2014
Dow University of Health Sciences
Information provided by (Responsible Party):
Saima Aziz Siddiqui, Dow University of Health Sciences
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||February 2014|
|Estimated Study Completion Date :||March 2014|